Perspectives: Does amiodarone increase non-sudden deaths? If so, why?

Journal of Interventional Cardiac Electrophysiology

Volumn 4, Issue 4, 2000, Pages 569-574

  Auricchio, Angelo ^a   Nisam, Seah ^b   Klein, Helmut U ^a  

^a UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

^b NONE

Author keywords

Amiodarone; Heart failure; Resynchronization therapy; Sudden cardiac death; Ventricular conduction delay

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; PLACEBO;

CLINICAL TRIAL; DRUG EFFICACY; DRUG MECHANISM; HEART ARRHYTHMIA; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; META ANALYSIS; MORTALITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SUDDEN DEATH;

AMIODARONE; ANTI-ARRHYTHMIA AGENTS; DEATH, SUDDEN; DEATH, SUDDEN, CARDIAC; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; INCIDENCE; MALE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TACHYCARDIA, VENTRICULAR;

EID: 0034500518     PISSN: 1383875X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026505329169     Document Type: Review

References (48)

1. Prevalence and significance of nonsustained ventricular tachycardia in patients with premature ventricular contractions and heart failure treated with vasodilator therapy
2. Clinical and objective improvements in severe congestive heart failure patients using univentricular or biventricular pacing: Preliminary results of a randomized prospective study
3. Benefits of optimized atrioventricular pacing on right, left or biventricular sites evaluated by 6-minute walk test
4. Effect of chronic multisite pacing on left ventricular volumes in patients with congestive heart failure
5. Randomized trial of effect of amiodarone on mortality in patients with left ventricular dysfunction after recent myocardial infarction
6. Randomized trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT
7. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia
8. Improved survival with an implanted defibrillator in patients with coronary disease at high risk of ventricular arrhythmias
9. Long-term results of amiodarone therapy with recurrent sustained ventricular tachycardia or ventricular fibrillation
10. Long-term outcome with the automatic implantable cardiover defibrillator
11. Causes of death in the Antiarrhythmics vs Implantable Defibrillators (AVID) Trial
12. Identification of patients most likely to benefit from implantable cardioverter-defibrillator therapy: The Canadian Implantable Defibrillator Study
13. Cellular electropharmacology of amiodarone
14. Proarrhythmia with class III antiarrythmic drugs: Definition, electrophysiologic mechanisms, incidence, predisposing factors, and clinical implication
15. Divergent effects of chronic amiodarone administration on systolic and diastolic function in patients with heart failure
16. Mechanisms of depressed conduction from long-term amiodarone therapy in canine myocardium
17. Hemodynamic effects of antiarrhythmic compounds: Intrinsic effects and autonomic modulation
18. Hemodynamic effects and tolerability of intravenous amiodarone in patients with impaired ventricular function
19. Chronic effects of amiodarone in patients with refractory ventricular tachycardia
20. Letter-to-the-Editor
21. Effects of long-term treatment with amiodarone on exercise hemodynamics and left ventricular relaxation in patients with hypertrophic cardiomyopathy
22. Effect of amiodarone of ventricular function as measured by gated radionuclide angiography
23. High dose oral amiodarone loading exerts important hemodynamic actions in patients with congestive heart failure
24. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation
25. The prognostic significance of quantitative signal-averaged variables relative to clinical variables, site of myocardial infarction, ejection fraction and ventricular premature beats: A prospective study
26. Natural history of abnormal conduction and its relation to prognosis in patients with dilated cardiomyopathy
27. Relation of left ventricular isovolumic relaxation time and incoordination to transmitral Doppler filling patterns
28. Electrical and hemodynamic correlates of the maximal rate of pressure increase in the human left ventricle
29. Mechanical dyssynchrony dilated cardiomyopathy with intraventricular conduction delay as depicted by 3D tagged magnetic resonance imaging
30. Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay
31. The Pacing Therapies for Congestive Heart Failure Study. Rationale, design and end-points of a prospective randomized multicenter study
32. The effect of pacing chamber and atrioventricular delay on acute systolic function of paced patients with congestive heart failure
33. Does fusion contribute to the improvement of LV systolic function of heart failure patients when pacing the LV with varying AV-delays?
34. Multisite Pacing as a supplemental treatment of congestive heart failure: Preliminary results of the Medtronic Inc InSync Study
35. Influence of the implantable cardioverter/defibrillator on sudden death and mortality in patients evaluated for cardiac transplantation
36. Effect of amiodarone on clinical status and left ventricular fuction in patients with congestive heart failure
37. Randomized trial of low-dose amiodarone in severe congestive heart failure
38. Amiodarone in patients with heart failure
39. Heart rate is a marker of amiodarone mortality reduction in severe heart failure
40. Can Implantable defibrillators reduce nonarrhythmic mortality?
41. Acute electrophysiological effects of amiodarone in patients with congestive heart failure
42. Are preload and optimum pacing mode associated in CHF patients?
43. Can intraventricular electromechanical synchrony account for the increase in LV-dP/dt when pacing heart failure patients at left ventricular lateral wall?
44. Target heart failure populations for newer therapies
45. Survival after implantation of the cardioverter defibrillator
46. Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in post infarct sudden death survivors